DrugPatentWatch Database Preview

Siga Technologies Company Profile

« Back to Dashboard

What is the competitive landscape for SIGA TECHNOLOGIES, and when can generic versions of SIGA TECHNOLOGIES drugs launch?

SIGA TECHNOLOGIES has one approved drug.

There are six US patents protecting SIGA TECHNOLOGIES drugs.

Summary for Siga Technologies

US Patents:	6
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Siga Technologies

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Siga Technologies	TPOXX	tecovirimat	CAPSULE;ORAL	208627-001	Jul 13, 2018		RX	Yes	Yes	8,124,643		Y	Y
Siga Technologies	TPOXX	tecovirimat	CAPSULE;ORAL	208627-001	Jul 13, 2018		RX	Yes	Yes	8,802,714
Siga Technologies	TPOXX	tecovirimat	CAPSULE;ORAL	208627-001	Jul 13, 2018		RX	Yes	Yes	9,339,466		Y	Y
Siga Technologies	TPOXX	tecovirimat	CAPSULE;ORAL	208627-001	Jul 13, 2018		RX	Yes	Yes	8,530,509		Y
Siga Technologies	TPOXX	tecovirimat	CAPSULE;ORAL	208627-001	Jul 13, 2018		RX	Yes	Yes	8,039,504		Y
Siga Technologies	TPOXX	tecovirimat	CAPSULE;ORAL	208627-001	Jul 13, 2018		RX	Yes	Yes
Siga Technologies	TPOXX	tecovirimat	CAPSULE;ORAL	208627-001	Jul 13, 2018		RX	Yes	Yes	7,737,168

Non-Orange Book US Patents for Siga Technologies

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
2,008,103,181
9,744,154	Polymorphic forms of ST-246 and methods of preparation
9,045,418	Compounds, compositions and methods for treatment and prevention of Orthopoxvirus infections and associated diseases
7,956,197	Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
7,687,641	Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

International Patents for Siga Technologies Drugs

Country	Document Number	Estimated Expiration
South Korea	20170102070
Israel	241731
South Korea	20130018271
South Korea	20160062208
China	104758281
Canada	2866037
Brazil	112012023743

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Siga Technologies